Tools

LEADER 03156nam a2200493 a 4500

001 ssj0000876664;

003 WaSeSS;

005 20220713083714.0;

006 m d ;

007 cr n ;

008 130314s2013 flua sb 001 0 eng d;

010 a| 2013010316;

020 a| 9781466587144 (hardback : alk. paper);

020 a| 1466587148 (hardback : alk. paper);

035 a| (WaSeSS)ssj0000876664;

040 a| DNLM/DLCc| DLCd| DLCd| WaSeSS;

042 a| pcc;

049 a| EREEa| NEHH;

050 10 a| RC670b| .B56 2013;

060 10 a| WG 141;

082 00 a| 616.1/0752| 23;

245 00 a| Biomarkers in cardiovascular diseasesh| [electronic resource] /c| editors, Dimitris Tousoulis, Christodoulos Stefanadis.;

260 a| Boca Raton :b| CRC Press,;

300 a| viii, 442 p. :b| ill. ;c| 24 cm.;

504 a| Includes bibliographical references and index.;

506 a| Available only to authorized users.;

520 a| "The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book"--Provided by publisher.;

538 a| Mode of access: World Wide Web;

650 12 a| Cardiovascular Diseasesx| diagnosis.=| ^A917669;

650 12 a| Cardiovascular Diseasesx| prevention & control.=| ^A919799;

650 22 a| Biological Markers.?| UNAUTHORIZED;

650 22 a| Risk Factors.=| ^A925035;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Tousoulis, Dimitris.?| UNAUTHORIZED;

700 1 a| Stefanadis, Christodoulos.=| ^A994858;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=1335842;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5857413;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5857413-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 7/16/2022x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5857413-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 7/16/2022x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5857413-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 7/16/2022x| EBOOKz| JERESOURCE;

Biomarkers in cardiovascular diseases / editors, Dimitris Tousoulis, Christodoulos Stefanadis.

Other author	Tousoulis, Dimitris.
Other author	Stefanadis, Christodoulos.
Format	Electronic
Publication Info	Boca Raton : CRC Press,
Description	viii, 442 p. : ill. ; 24 cm.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Cardiovascular Diseases--diagnosis. Cardiovascular Diseases--prevention & control. Biological Markers. Risk Factors.

Abstract	"The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book"--Provided by publisher.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2013010316
ISBN	9781466587144 (hardback : alk. paper)
ISBN	1466587148 (hardback : alk. paper)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Biomarkers in cardiovascular diseases / editors, Dimitris Tousoulis, Christodoulos Stefanadis.

Click here for more information about this title

Availability